Contemporary Clinic Editorial Staff

Contemporary Clinic spoke with Daniel R. Wilson, MD, PhD, President of Western University of Health Sciences, about what to recommend to those who are struggling cognitively through the COVID-19 pandemic.

Wilson reminded those who may be stressed since the start of the pandemic to continue to take care of both your body and mind, such as eating well, sleeping well, and socializing when possible.

Wilson also shared his thoughts on what he hopes to see for the future of COVID-19 and the focus of future studies on it. 

Videos

The Future of Neurological Studies During COVID-19

Contemporary Clinic spoke with Daniel R. Wilson, MD, PhD, President of Western University of Health Sciences, about the impact that COVID-19 is having on the brain.

Wilson explained how certain people with COVID-19 are experiencing post-COVID-19 symptoms of cognitive changes, such as clarity in thinking and memory. 

In addition, Wilson also discusses the importance of focusing on the cognitive long-term effects of the virus and specific trials regarding this topic. 

The Neurological Impact of COVID-19

Contemporary Clinic spoke with Teri Moser Woo, PhD, ARNP, CPNP-PC, CNL, FAANP, about Antibiotic Awareness Week.

Woo addressed that this week, which takes place from November 18-24, is a good time to reflect on what health care providers are actually prescribing, the appropriateness of what they are prescribing, and to know if each antibiotic is the right one for the pathogen that you are treating. 

Woo also discussed the COVID-19 pandemic, stewardships, the threat of antibiotic resistance, and the future of nurse practitioners with antibiotics. 

What to Know Ahead of Antibiotic Awareness Week 2020

Contemporary Clinic spoke with Gregg Sylvester, chief medical officer at Seqirus, about the new trivalent influenza vaccine, aTIV, and its implications for practitioners.

Sylvester emphasized that vaccines are very important in preventing disease, beyond just influenza. However, if we focus on just influenza, they have evolved and improved over time. 

"This adjuvanted trivalent influenza vaccine that we're talking about now was shown in 2017/2018 to actually reduce office visits and hospitalizations compared to the standard flu vaccine," Sylvester said. 

Sylvester also discussed the importance of this data for vulnerable populations, implications for practitioners and other health care professionals, and what he hopes to see for the future of aTIV and other vaccines. 

Articles

The Future of Neurological Studies During COVID-19

The Neurological Impact of COVID-19

What to Know Ahead of Antibiotic Awareness Week 2020

New Trivalent Influenza Vaccine and Implications for Practitioners